CUE

Cue Biopharma, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

8

Buys

6

Sells

1

Largest Trade

$1M+

Insiders

6

Institutional Funds

42

Inst. Value

$1M+

Activist Filings

13

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Sarraf PashaDirectorBUY$50K–$100K324K$0.31Jan 2, 2026
Suri AnishPRESIDENT AND CSOBUY$1K–$15K4K$2.76Aug 29, 2023
PASSERI DANIEL RCHIEF EXECUTIVE OF…BUY$1K–$15K3K$2.86Aug 16, 2023
Kiener Peter ADirectorSELL$15K–$50K9K$3.28Mar 27, 2023
Kiener Peter ADirectorEXERCISE$15K–$50K10K$2.86Mar 27, 2023
Morich FrankDirectorBUY$100K–$500K28K$3.75May 31, 2022
Fletcher Aaron G.L.DirectorBUY$500K+205K$3.47May 25, 2022
Fletcher Aaron G.L.DirectorBUY$1M+735K$4.76Apr 4, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 42 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Mark E. Strome

SC 13G/A · May 16, 2025

5.0%

2.2M shares

Bleichroeder LP

SC 13G/A · Mar 21, 2025

10.0%

6.1M shares

Slate Path Capital LP

SC 13G/A · Feb 14, 2025

1.4%

919K shares

Bleichroeder LP

SC 13G/A · Oct 7, 2024

10.0%

6.1M shares

BlackRock, Inc.

SC 13G · Jan 31, 2024

5.2%

2.3M shares

Slate Path Capital LP

SC 13G · Feb 14, 2023

5.6%

2.4M shares

Nantahala Capital Management, LLC

SC 13G/A · Dec 2, 2022

0.3%

93K shares

Slate Path Master Fund LP

SC 13G · Nov 18, 2022

5.6%

2.4M shares

BlackRock, Inc.

SC 13G · Jul 8, 2022

2.4%

832K shares

Corriente Advisors, LLC

SC 13G/A · Feb 14, 2022

0.0%

0 shares

Nantahala Capital Management, LLC

SC 13G/A · Feb 14, 2022

8.0%

2.5M shares

View on Google Finance →